Targeted Modulation of the Neuroinflammatory Response after Spinal Cord Injury: The Ongoing Quest for the “Holy Grail”
- 31 December 2010
- journal article
- comment
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 177 (6), 2685-2687
- https://doi.org/10.2353/ajpath.2010.100408
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Targeted Inhibition of the Complement Alternative Pathway with Complement Receptor 2 and Factor H Attenuates Collagen Antibody-Induced Arthritis in MiceThe Journal of Immunology, 2009
- Inflammation: Beneficial or Detrimental After Spinal Cord Injury?Recent Patents on CNS Drug Discovery, 2008
- Advanced Trauma Life Support, 8th Edition, The Evidence for ChangeThe Journal of Trauma and Acute Care Surgery, 2008
- Repair of the Injured Spinal CordNeurodegenerative Diseases, 2007
- Complement Plays an Important Role in Spinal Cord Injury and Represents a Therapeutic Target for Improving Recovery following TraumaThe American Journal of Pathology, 2006
- Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activationBMC Neuroscience, 2006
- The role of the complement system in CNS inflammatory diseasesExpert Review of Clinical Immunology, 2006
- The Central Role of the Alternative Complement Pathway in Human DiseaseThe Journal of Immunology, 2006
- Regulation of the Complement Membrane Attack PathwayCritical Reviews™ in Immunology, 1999
- Complement elevation in spinal cord injury.1980